Results of the COAPT Study at 5 Years: Sustained Benefit of the MitraClip When Surgery Is Not Feasible?
The COAPT study’s 5-year outcomes assess clinical parameters and mortality in patients with severe secondary mitral regurgitation (MR) after MitraClip implantation.
Coronary Artery Bypass Grafting vs. Percutaneous Intervention in Patients with NSTE-ACS: No News, Good News
Comparative meta-analysis of prospective studies on urgent revascularization in patients with multivessel disease presenting specifically as Non-ST-Elevation Acute Coronary Syndrome (NSTE-ACS), via coronary artery bypass grafting or percutaneous intervention.
On-X mitral: Is Reduced Oral Anticoagulation Feasible?
This study is a randomized, multicenter, prospective, open clinical trial comparing clinical outcomes 3 months after implanting an On-X mechanical mitral prosthesis in patients with standard anticoagulation ranges versus a lower target.
Percutaneous Tricuspid Repair: The Definitive Treatment for Moderate- or High-Risk Surgical Patients?
This is a multicenter, randomized clinical trial evaluating outcomes of transcatheter edge-to-edge tricuspid valve repair compared to optimized medical management in 350 patients with severe tricuspid regurgitation.
Transcatheter aortic valve implantation versus surgical aortic valve replacement in aortic insufficiency: is it justified?
Analysis of post-procedure outcomes and mid-term follow-up of TAVI vs. SVA in a U.S. healthcare insurance database for patients with pure aortic insufficiency.
Results of Percutaneous or Surgical Revascularization by SYNTAX Score Stratification: The Beginning of the End?
This meta-analysis, encompassing 6 clinical trials, compares percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in cases of left main coronary artery disease or multivessel disease, presenting results stratified according to the SYNTAX score.
Early lead extraction for infected implanted cardiac electronic devices
This review, published in JACC, addresses the global impact of infections in implanted cardiac electronic devices (CIEDs), providing treatment recommendations and potential improvements in application.
ECMO-CS Study: Does It Clarify When to Implant VA-ECMO in Cardiogenic Shock?
First multicenter randomized clinical trial assessing the outcomes of immediate VA-ECMO implantation compared to an initially conservative strategy (allowing subsequent VA-ECMO if hemodynamic deterioration occurs) in patients with severe or rapidly deteriorating cardiogenic shock.
